Effects of UVA irradiation, aryl azides, and reactive oxygen species on the orthogonal inactivation of the human immunodeficiency virus (HIV-1)

被引:10
作者
Belanger, Julie M. [1 ]
Raviv, Yossef [2 ]
Viard, Mathias [2 ]
de la Cruz, M. Jason [3 ]
Nagashima, Kunio [3 ]
Blumenthal, Robert [1 ]
机构
[1] NCI, Ctr Canc Res, Nanobiol Program, Bethesda, MD 20892 USA
[2] NCI Frederick, Basic Res Program, SAIC Frederick Inc, Frederick, MD 21702 USA
[3] NCI Frederick, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
HIV; Detergent; Vaccine; Triton; Hydrophobic; Azide; Reactive oxygen species (ROS); Viral membrane; STRUCTURAL INTEGRITY; IMMUNE-RESPONSES; TYPE-1; PRESERVATION; ENVELOPE; VACCINES; PROTEIN; IMMUNOGENICITY; VACCINATION; EPITOPES;
D O I
10.1016/j.virol.2011.06.007
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Previously we reported that hydrophobic aryl azides partition into hydrophobic regions of the viral membrane of enveloped viruses and inactivate the virus upon UVA irradiation for 2 min. Prolonged irradiation (15 min) resulted in viral protein aggregation as visualized via Western blot analysis, due to reactive oxygen species (ROS) formation, with preservation of the surface antigenic epitopes. Herein, we demonstrate that these aggregates show detergent resistance and that this property may be useful towards the creation of a novel orthogonal virus inactivation strategy for use in preparing experimental vaccines. When ROS-modified HIV virus preparations were treated with 1% Triton X-100, there was an increase in the percent of viral proteins (gp41, p24) in the viral pellet after ultracentrifugation through sucrose. Transmission electron microscopy (TEM) of these detergent-resistant pellets shows some recognizable virus fragments, and immunoprecipitation studies of the gp41 aggregates suggest the aggregation is covalent in nature, involving short-range interactions. Published by Elsevier Inc.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 26 条
[1]   EFFECT OF ALKALINE GLUTARALDEHYDE ON HEPATITIS-B VIRUS-ANTIGENS [J].
ADLERSTORTHZ, K ;
SEHULSTER, LM ;
DREESMAN, GR ;
HOLLINGER, FB ;
MELNICK, JL .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (04) :316-320
[2]   IMMUNOGENICITY OF A VIRAL MODEL VACCINE AFTER DIFFERENT INACTIVATION PROCEDURES [J].
BACHMANN, MF ;
BAST, C ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1994, 183 (02) :95-104
[3]   Characterization of the Effects of Aryl-azido Compounds and UVA Irradiation on the Viral Proteins and Infectivity of Human Immunodeficiency Virus Type 1 [J].
Belanger, Julie M. ;
Raviv, Yossef ;
Viard, Mathias ;
de la Cruz, Michael Jason ;
Nagashima, Kunio ;
Blumenthal, Robert .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2010, 86 (05) :1099-1108
[4]   5-[I-125]IODONAPHTHYL AZIDE, A REAGENT TO DETERMINE PENETRATION OF PROTEINS INTO LIPID BILAYER OF BIOLOGICAL-MEMBRANES [J].
BERCOVICI, T ;
GITLER, C .
BIOCHEMISTRY, 1978, 17 (08) :1484-1489
[5]   LIPID AND PROTEIN ORGANIZATION IN VESICULAR STOMATITIS AND SINDBIS VIRUSES [J].
BROWN, F ;
SMALE, CJ ;
HORZINEK, MC .
JOURNAL OF GENERAL VIROLOGY, 1974, 22 (MAR) :455-458
[6]  
BROWN F, 1993, DEV BIOL STAND, V81, P103
[7]   Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus [J].
Chertova, E ;
Bess, JW ;
Crise, BJ ;
Sowder, RC ;
Schaden, TM ;
Hilburn, JM ;
Hoxie, JA ;
Benveniste, RE ;
Lifson, JD ;
Henderson, LE ;
Arthur, LO .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5315-5325
[8]  
Coligan J.E., 2001, CURR PROTOC IMMUNOL
[9]   The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice [J].
Cox, Rebecca Jane ;
Hovden, Arnt-Ove ;
Brokstad, Karl Albert ;
Szyszko, Ewa ;
Madhun, Abdullah Sami ;
Haaheim, Lars Reinhardt .
VACCINE, 2006, 24 (44-46) :6585-6587
[10]   EFFECTS OF FORMALIN INACTIVATION ON BOVINE HERPES VIRUS-1 GLYCOPROTEINS AND ANTIBODY-RESPONSE ELICITED BY FORMALIN-INACTIVATED VACCINES IN RABBITS [J].
DUQUE, H ;
MARSHALL, RL ;
ISRAEL, BA ;
LETCHWORTH, GJ .
VACCINE, 1989, 7 (06) :513-520